A Booster for Radiofrequency Ablation: Advanced Adjuvant Therapy via In Situ Nanovaccine Synergized with Anti-programmed Death Ligand 1 Immunotherapy for Systemically Constraining Hepatocellular Carcinoma
ACS Nano · 2023
DOI: 10.1021/acsnano.3c08064 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Nano, 2023. Verfasst von Zhou Tian und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery, The Fourth Affiliated Hospital, Zhejiang University School of Medicine, Yiwu, Zhejiang 322000, China. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Immunotherapy, Radiofrequency Ablation. Die Arbeit wurde bisher 57-mal zitiert (Crossref) und nennt 72 Literaturangaben. Gefördert von: Primary Research and Development Plan of Zhejiang Province, National Natural Science Foundation of China, Jinhua Science and Technology Bureau.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of General Surgery, The Fourth Affiliated Hospital, Zhejiang University School of Medicine, Yiwu, Zhejiang 322000, China.
- Institute of Immunology, School of Medicine, Zhejiang University, Hangzhou, Zhejiang 310000, China.
- Department of Ultrasonography, The Fourth Affiliated Hospital, Zhejiang University School of Medicine, Yiwu, Zhejiang 322000, China.
- Department of Surgery, The Second Affiliated Hospital, Zhejiang University School of Medicine, HangZhou, Zhejiang 310000, China.
- Department of Respiratory and Critical Care Medicine, The Fourth Affiliated Hospital, Zhejiang University School of Medicine, Yiwu, Zhejiang 322000, China.
- International Institutes of Medicine, The Fourth Affiliated Hospital of Zhejiang University School of Medicine, Yiwu, Zhejiang 322000, China.
ORCID-Profile: Zhou Tian, Weiyu Chen
Förderung
- Primary Research and Development Plan of Zhejiang Province
- National Natural Science Foundation of China
- Jinhua Science and Technology Bureau
- Natural Science Foundation of Zhejiang Province
- Huadong Medicine
Zitieren
APA
Tian, Z., Hu, Q., Sun, Z., Wang, N., He, H., Tang, Z., & Chen, W. (2023). A Booster for Radiofrequency Ablation: Advanced Adjuvant Therapy via In Situ Nanovaccine Synergized with Anti-programmed Death Ligand 1 Immunotherapy for Systemically Constraining Hepatocellular Carcinoma. ACS Nano. https://doi.org/10.1021/acsnano.3c08064
Vancouver
Tian Z, Hu Q, Sun Z, Wang N, He H, Tang Z, et al. A Booster for Radiofrequency Ablation: Advanced Adjuvant Therapy via In Situ Nanovaccine Synergized with Anti-programmed Death Ligand 1 Immunotherapy for Systemically Constraining Hepatocellular Carcinoma. ACS Nano. 2023. doi:10.1021/acsnano.3c08064
BibTeX
@article{Tian2023,
author = {Tian, Zhou and Hu, Qitao and Sun, Zhouyi and Wang, Ning and He, Huiling and Tang, Zhe and Chen, Weiyu},
title = {A Booster for Radiofrequency Ablation: Advanced Adjuvant Therapy via In Situ Nanovaccine Synergized with Anti-programmed Death Ligand 1 Immunotherapy for Systemically Constraining Hepatocellular Carcinoma},
journal = {ACS Nano},
year = {2023},
doi = {10.1021/acsnano.3c08064}
}
EUVIMED